The FDA has granted accelerated approval to Modeyso™ (dordaviprone) as the first treatment for recurrent H3 K27M-mutant ...

The FDA has accepted Bristol Myers Squibb’s Priority Review application for Breyanzi® (lisocabtagene maraleucel) as a ...

This weekend, the Pan-Mass Challenge (PMC) unites more than 6,500 riders and 3,500 volunteers for its 46th ride, with the ...

Researchers have identified eIF2A as a key protein that guides melanoma cells during metastasis. Known for its role in aiding ...

A multi-institutional study found that 42% of ovarian cancer patients in clinical remission still harbored minimal residual ...

The ARANOTE trial showed that adding darolutamide to ADT reduced the risk of progression or death by 46% in metastatic ...

A novel radioimmunotherapy strategy has shown compelling efficacy in eliminating ovarian cancer stem cells in preclinical ...